December 2007 Sosei and Vectura Announce Start of Phase II Efficacy Study of QVA149 December 2007 Sosei Announces New Fundraising November 2007 Sosei Announces Approval to Start AD 923 Phase III Studies in Europe November 2007 Sosei Announces Update on Phase I Trials for SD118 November 2007 Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD November 2007 Summary of Consolidated Financial Results for the First Half Year ended 30th September 2007 (abridged English version ) September 2007 Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome August 2007 Sosei Announces Completion of Phase I Trial for NorLevo® August 2007 Summary of Consolidated Financial Results for the First Quarter ended 30th June 2007 (abridged English version) August 2007 Sosei and Vectura Announce Start of Phase II Clinical Study with NVA237 in the USA July 2007 Vectura and Sosei Announce NVA237 Dose Ranging Study in New Device May 2007 Sosei Announces Start of SD118 Phase I Studies May 2007 Sosei Announces New Appointments to its Board of Directors May 2007 Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA May 2007 Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2007 March 2007 Sosei Announces Completion of Exercise of Stock Acquisition Rights March 2007 Sosei Announces Significant Exercise of Stock Acquisition Rights March 2007 Sosei Announces Significant Exercise of Stock Acquisition Rights March 2007 AD 923 Commences Phase I Clinical Development in the USA March 2007 Sosei Announces Significant Exercise of Stock Acquisition Rights February 2007 Sosei Announces Progression of SD118 Towards Phase I Studies February 2007 Summary of Consolidated Financial Results for the 3Q Ended 31st December 2006 (abridged English version) January 2007 Sosei Announces Significant Exercise of Stock Acquisition Rights January 2007 Sosei Announces New Fundraising 2008 | 2007 | 2006 | 2005 | 2004